Atomic AI Launches with $35 Million Series A Financing to Advance AI-driven RNA Structure Platform for Treating Undruggable Diseases
Atomic AI Launches with $35 Million Series A Financing to Advance AI-driven RNA Structure Platform for Treating Undruggable Diseases (January 25, 2023) | By BUSINESS WIRE. SAN FRANCISCO — (BUSINESS
TOP 50 Microbiome posts out of hundreds of posts as rated by Impressions 1,300,000 + Impressions on LinkedIn
By Ross Youngs, January 18, 2023. TOP 50 Microbiome posts out of hundreds of posts as rated by Impressions 1,300,000 + Impressions on LinkedIn The impression created a ranking of Ross’
What’s in store for biotech in 2023?
What’s in store for biotech in 2023? Perhaps 2022 will best be remembered in the life science industry for the return of many of the face-to-face events that fell by
BIOHM Raises $7.5 Million to Accelerate Microbiome Research, Artificial Intelligence Capabilities and Product Development
BIOHM Raises $7.5 Million to Accelerate Microbiome Research, Artificial Intelligence Capabilities and Product Development (January 12, 2023) | By BIOHM Health. The funding round, led by Middleland Capital’s VTC Ventures,
Battelle, AmplifyBio, Andelyn team up NIH contract targeting stroke, neurological disease
Battelle, AmplifyBio, Andelyn team up NIH contract targeting stroke, neurological disease (January 10, 2023) | By Carrie Ghose – Staff reporter. A team comprising Battelle and two Central Ohio biotech
Biosortia Microbiomics to Present at Biotech Showcase™ 2023
Biosortia Microbiomics to Present at Biotech Showcase™ 2023 Biosortia’s proven technology obtains nature’s previously inaccessible drug-like small molecules for treatments and cures
Coffee Table Science
Coffee Table Science